Literature DB >> 33661943

Validation of the loop-mediated isothermal amplification method for rapid and sensitive detection of Ureaplasma species in respiratory tracts of preterm infants.

Yuta Mikami1,2, Kazumasa Fuwa3, Eriko Arima4, Yasuo Suda4, Itaru Yanagihara5, Satoshi Ibara1.   

Abstract

INTRODUCTION: A simple and rapid diagnosis of Ureaplasma spp. is required for the choice of the appropriate antibiotic. However, an ideal detection method has not been available. This study examines the efficacy of the loop-mediated isothermal amplification (LAMP) assay, which provides rapid and sensitive results, to detect Ureaplasma spp. in respiratory tract samples of preterm infants.
METHODS: The study included preterm infants born before 32 weeks of gestation admitted Kagoshima City Hospital from June 2018 to March 2020. Nasopharyngeal swabs and/or tracheal aspirates were obtained in the first seven postnatal days. One hundred sixty-seven nasopharyngeal swabs and 101 tracheal aspirates were analyzed by LAMP, culture, and quantitative real-time polymerase chain reaction.
RESULTS: All 167 infants had a median (range) gestational age of 28.7 weeks (22.3-30.9) and birthweight 1030g (322-1828). One hundred sixty-seven nasopharyngeal swabs and 101 tracheal aspirates were obtained. In the results of nasopharyngeal swabs, the sensitivity and specificity of LAMP were 73.9% (17/23) and 97.2% (140/144), whereas those of quantitative real-time polymerase chain reaction were 73.9% (17/23) and 95.8% (138/144), compared to culture. In the results of tracheal aspirates, the sensitivity and specificity of LAMP were 89.5% (17/19) and 92.7% (76/82), whereas those of quantitative real-time polymerase chain reaction were 89.5% (17/19) and 93.9% (77/82), compared to culture.
CONCLUSIONS: The LAMP assay showed similar sensitivity and specificity with quantitative real-time polymerase chain reaction in the respiratory tracts of preterm infants including extremely preterm infants during the immediate postnatal period. Therefore, the LAMP is a practical alternative for the early detection so that appropriate antibiotics can be administered for preventing BPD.

Entities:  

Year:  2021        PMID: 33661943      PMCID: PMC7932158          DOI: 10.1371/journal.pone.0247618

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  27 in total

1.  Detection of Mycobacterium tuberculosis complex in sputum specimens using a loop-mediated isothermal amplification assay in Korea.

Authors:  Se Hoon Moon; Eun Jin Kim; Jun Tomono; Shigehiko Miyamoto; Satoshi Mitarai; Dong Wook Kim; Mitsuko Seki
Journal:  J Med Microbiol       Date:  2015-09-02       Impact factor: 2.472

2.  Placental features of chorioamnionitis colonized with Ureaplasma species in preterm delivery.

Authors:  Fumihiko Namba; Taeko Hasegawa; Masahiro Nakayama; Takuro Hamanaka; Tatsuyuki Yamashita; Kumiko Nakahira; Akihito Kimoto; Masatoshi Nozaki; Masahiro Nishihara; Kazuya Mimura; Minoru Yamada; Hiroyuki Kitajima; Noriyuki Suehara; Itaru Yanagihara
Journal:  Pediatr Res       Date:  2010-02       Impact factor: 3.756

Review 3.  Association between pulmonary ureaplasma colonization and bronchopulmonary dysplasia in preterm infants: updated systematic review and meta-analysis.

Authors:  John Lowe; W John Watkins; Martin O Edwards; O Brad Spiller; Evelyne Jacqz-Aigrain; Sarah J Kotecha; Sailesh Kotecha
Journal:  Pediatr Infect Dis J       Date:  2014-07       Impact factor: 2.129

4.  Clarithromycin in preventing bronchopulmonary dysplasia in Ureaplasma urealyticum-positive preterm infants.

Authors:  Ramazan Ozdemir; Omer Erdeve; Evrim Alyamac Dizdar; Serife Suna Oguz; Nurdan Uras; Sibel Saygan; Erdem Karabulut; Ugur Dilmen
Journal:  Pediatrics       Date:  2011-11-28       Impact factor: 7.124

Review 5.  Ureaplasma species: role in diseases of prematurity.

Authors:  Rose M Viscardi
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

6.  Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial.

Authors:  Hubert O Ballard; Lori A Shook; Philip Bernard; Michael I Anstead; Robert Kuhn; Vicki Whitehead; Deb Grider; Timothy N Crawford; Don Hayes
Journal:  Pediatr Pulmonol       Date:  2010-10-20

7.  Antenatal Ureaplasma urealyticum respiratory tract infection stimulates proinflammatory, profibrotic responses in the preterm baboon lung.

Authors:  Rose M Viscardi; Sergei P Atamas; Irina G Luzina; Jeffrey D Hasday; Ju-Ren He; Patricia J Sime; Jacqueline J Coalson; Bradley A Yoder
Journal:  Pediatr Res       Date:  2006-08       Impact factor: 3.756

Review 8.  Ureaplasma species: role in neonatal morbidities and outcomes.

Authors:  Rose Marie Viscardi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2013-08-19       Impact factor: 5.747

Review 9.  Role of Ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence.

Authors:  Rose Marie Viscardi; Jeffrey D Hasday
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

10.  Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.

Authors:  Hubert O Ballard; Michael I Anstead; Lori A Shook
Journal:  Respir Res       Date:  2007-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.